Orbis Investment Management Ltd Increases Stake in Genmab A/S to 5.5%

This Schedule 13G/A filing, dated May 15, 2026, details an increased position in Genmab A/S (GMAB) by Orbis Investment Management Ltd and Allan Gray Australia Pty Ltd. As of the event date on March 31, 2026, the reporting persons collectively beneficially own 3,557,484 shares of common stock, representing a 5.5% ownership stake in the company. Individually, Orbis Investment Management Ltd holds the vast majority of this position with 3,549,674 shares, while Allan Gray Australia Pty Ltd holds 7,810 shares. This represents a significant increase from a previously reported 0.0% ownership level. Both entities are classified as non-U.S. institutions equivalent to investment advisers. The filing indicates that the shares were acquired in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer. Both reporting persons disclaim beneficial ownership of shares held by the other and maintain that they do not constitute a formal group under Section 13(d)(3) of the Securities Exchange Act.